A reporter for MS News Today asked this question, but the answers provided frustrate me. One response was that it depends on how you define “cure.” Another pointed to progress in halting disease progression but didn’t address “cure.” Yet another said, “We still have some way to go.” But will there ever be a cure? I didn’t see a solid answer. Maybe there is none.
It is a question that multiple sclerosis (MS) patients, loved ones, and the larger community have asked for some time: “Will there be a cure for multiple sclerosis?”
There’s an app for almost everything, and more apps are being created to assist with MS evaluation or treatment. This one is designed to conduct walking, dexterity, vision, and cognition tests similar to those carried out in a neurologist’s office. But the advantage of this app is that a patient can use it anywhere.
MSCopilot, a software device designed for the self-assessment of multiple sclerosis (MS), distinguishes between patients and healthy controls, and potentially could be used in clinical practice for the monitoring of MS disability progression and patients’ response to treatment.
Here’s another story about new technology developed to help treat multiple sclerosis (MS). And they’re looking for a handful of volunteers to test it.
Researchers at Kent and Canterbury Hospital, U.K., are recruiting 20 patients with multiple sclerosis (MS) who can walk at least eight meters with a walking aid to test the effectiveness of a five-week exercise program using assistive robotic technology.
The Rex device — made by Rex Bionics — is a maneuverable exoskeleton that straps to and supports a patient’s feet, legs, and core, while leaving their hands free to function normally.
I’ve read many word-of-mouth reports of people with MS who swear by Botox treatments to help them with bladder control problems. This study reports satisfaction by patients and clinicians who used Botox to treat arm and leg spasticity.
Patients with a range of diseases and disorders, including multiple sclerosis (MS), report high satisfaction with botulinum toxin — also known as Botox (onabotulinumtoxinA) — as a treatment for spasticity, results from the ASPIRE clinical trial show.
Note: Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The opinions expressed in this column are not those of Multiple Sclerosis News Today or its parent company, BioNews Services, and are intended to spark discussion about issues pertaining to multiple sclerosis.
Diagnosed with MS at age 32 in 1980, Ed has written the “MS Wire” column for Multiple Sclerosis News Today since August 2016. He presents timely information on MS, blended with personal experiences. Before retiring from full-time work in 2012, Tobias spent more than four decades in broadcast and on-line newsrooms as a manager, reporter, and radio news anchor. He’s won several national broadcast awards. As an MS patient communicator, Ed consults with healthcare and social media companies. He’s the author of “We’re Not Drunk, We Have MS: A tool kit for people living with multiple sclerosis.” Ed and his wife split time between the Washington, D.C. suburbs and Florida’s Gulf Coast.
Diagnosed with MS at age 32 in 1980, Ed has written the “MS Wire” column for Multiple Sclerosis News Today since August 2016. He presents timely information on MS, blended with personal experiences. Before retiring from full-time work in 2012, Tobias spent more than four decades in broadcast and on-line newsrooms as a manager, reporter, and radio news anchor. He’s won several national broadcast awards. As an MS patient communicator, Ed consults with healthcare and social media companies. He’s the author of “We’re Not Drunk, We Have MS: A tool kit for people living with multiple sclerosis.” Ed and his wife split time between the Washington, D.C. suburbs and Florida’s Gulf Coast.
We’ll be glad to have you join our email list. To do this, just scroll down on the home page until you get to where it says “Subscribe to our mailing list.” Fill in your name and email address and you’ll be added.
I’m interested in getting email alerts or content emails as new content is uploaded/published to the site
Hi Angel,
We’ll be glad to have you join our email list. To do this, just scroll down on the home page until you get to where it says “Subscribe to our mailing list.” Fill in your name and email address and you’ll be added.
Ed